Matricelf
Sector: Healthcare & Life Sciences
About Matricelf
Matricelf (TASE: MTLF) is a clinical-stage regenerative medicine company developing a platform for 3D bioprinting human tissues and organs. Their technology uses a patient's own (autologous) cells and extracellular matrix to eliminate the risk of tissue rejection.
Products
Matricelf’s autologous regenerative platform
Redefining personalized regenerative medicine through its groundbreaking platform for autologous 3D tissue engineering. The company develops curative, patient-specific therapies aimed at restoring function and independence in patients with severe neurological injuries. By engineering functional neural implants from a patient’s own cells and tissue, Matricelf offers a one-time treatment that has the potential to transform the standard of care and unlock broader therapeutic applications.